欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Helicobacter Test INFAI
适用类别Human
治疗领域Breath Tests;Helicobacter Infections
通用名/非专利名称13C-urea
活性成分urea (13C)
产品号EMEA/H/C/000140
患者安全信息No
许可状态Authorised
ATC编码V04CX
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期1997/08/14
上市许可开发者/申请人/持有人INFAI, Institut für biomedizinische Analytik NMR-Imaging GmbH
人用药物治疗学分组Diagnostic agents
兽用药物治疗学分组
审评意见日期1997/04/16
欧盟委员会决定日期2024/08/19
修订号21
治疗适应症Helicobacter Test INFAI may be used for in vivo diagnosis of gastroduodenal Helicobacter pylori infection in: adults; adolescents, who are likely to have peptic ulcer disease. Helicobacter Test INFAI for children aged three to 11 years may be used for in vivo diagnosis of gastrduodenal Helicobacter pylori infection: for the evaluation of the success of eradication treatment, or; when invasive tests cannot be performed, or; when there are discordant results arising from invasive tests. This medicinal product is for diagnostic use only.
适用物种
兽用药物ATC编码
首次发布日期2018/03/07
最后更新日期2024/08/20
产品说明书https://www.ema.europa.eu/en/documents/product-information/helicobacter-test-infai-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/human/EPAR/helicobacter-test-infai
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase